{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T15:38:20Z","timestamp":1791041900907,"version":"4.1.0"},"reference-count":48,"publisher":"Japanese Society for Pediatric Endocrinology","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Pediatr Endocrinol"],"published-print":{"date-parts":[[2024]]},"DOI":"10.1297\/cpe.2024-0005","type":"journal-article","created":{"date-parts":[[2024,2,25]],"date-time":"2024-02-25T17:12:09Z","timestamp":1708881129000},"page":"50-58","source":"Crossref","is-referenced-by-count":4,"title":["Genetic backgrounds and genotype-phenotype relationships in anthropometric          parameters of 116 Japanese individuals with Noonan syndrome"],"prefix":"10.1297","volume":"33","author":[{"given":"Yasuko","family":"Shoji","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Endocrinology, Osaka Women\u2019s and              Children\u2019s Hospital, Osaka, Japan"},{"name":"Department of Epidemiology and Health Policy, University of Toyama, Toyama,              Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayaha","family":"Hata","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Endocrinology, Osaka Women\u2019s and              Children\u2019s Hospital, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takatoshi","family":"Maeyama","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Endocrinology, Osaka Women\u2019s and              Children\u2019s Hospital, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamaki","family":"Wada","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Endocrinology, Osaka Women\u2019s and              Children\u2019s Hospital, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuiko","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Department of Genetics, Osaka Women\u2019s and Children\u2019s Hospital, Osaka,              Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eriko","family":"Nishi","sequence":"additional","affiliation":[{"name":"Department of Genetics, Osaka Women\u2019s and Children\u2019s Hospital, Osaka,              Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinobu","family":"Ida","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Osaka Women\u2019s and Children\u2019s Hospital,              Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri","family":"Etani","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Endocrinology, Osaka Women\u2019s and              Children\u2019s Hospital, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Niihori","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, Tohoku University School of Medicine,              Miyagi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Aoki","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, Tohoku University School of Medicine,              Miyagi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiko","family":"Okamoto","sequence":"additional","affiliation":[{"name":"Department of Genetics, Osaka Women\u2019s and Children\u2019s Hospital, Osaka,              Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanobu","family":"Kawai","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Endocrinology, Osaka Women\u2019s and              Children\u2019s Hospital, Osaka, Japan"},{"name":"Department of Bone and Mineral Research, Research Institute, Osaka Women\u2019s              and Children\u2019s Hospital, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"125","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Noonan,              JA.            Hypertelorism with Turner phenotype. A new syndrome with associated            congenital heart disease. Am J Dis Child          1968;116: 373\u201380.","DOI":"10.1001\/archpedi.1968.02100020377005"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Roberts,                AE,                Allanson,              JE,              Tartaglia, M,                Gelb,            BD. Noonan            syndrome. Lancet          2013;381: 333\u201342.","DOI":"10.1016\/S0140-6736(12)61023-X"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Aoki,              Y, Niihori,                T, Inoue,                S,                Matsubara,              Y. Recent            advances in RASopathies. J Hum Genet          2016;61: 33\u20139.","DOI":"10.1038\/jhg.2015.114"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. van der                Burgt, I,                Berends, E,                Lommen, E,                van Beersum,              S, Hamel,                B, Mariman,                E. Clinical            and molecular studies in a large Dutch family with Noonan syndrome.            Am J Med Genet          1994;53: 187\u201391.","DOI":"10.1002\/ajmg.1320530213"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Tartaglia,                M, Mehler,                EL,                Goldberg,            R, Zampino,                G, Brunner,                HG, Kremer,                H, et al.            Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2,            cause Noonan syndrome. Nat Genet          2001;29: 465\u20138.","DOI":"10.1038\/ng772"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Roberts,                AE, Araki,                T, Swanson,                KD,                Montgomery,              KT, Schiripo,                TA, Joshi,                VA, et al.            Germline gain-of-function mutations in SOS1 cause Noonan            syndrome. Nat Genet          2007;39: 70\u20134.","DOI":"10.1038\/ng1926"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Tartaglia,                M,                Pennacchio,              LA, Zhao,                C, Yadav,                KK, Fodale,                V, Sarkozy,                A, et al.            Gain-of-function SOS1 mutations cause a distinctive form of Noonan            syndrome. Nat Genet          2007;39: 75\u20139.","DOI":"10.1038\/ng1939"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Pandit,              B, Sarkozy,                A,                Pennacchio,              LA, Carta,                C, Oishi,                K,                Martinelli,              S, et al.            Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with            hypertrophic cardiomyopathy. Nat Genet          2007;39: 1007\u201312.","DOI":"10.1038\/ng2073"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Razzaque,                MA,                Nishizawa,              T, Komoike,                Y, Yagi,                H,              Furutani, M,                Amo, R,              et al. Germline gain-of-function mutations            in RAF1 cause Noonan syndrome. Nat Genet          2007;39: 1013\u20137.","DOI":"10.1038\/ng2078"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Schubbert,                S, Zenker,                M, Rowe,                SL, B\u00f6ll,                S, Klein,                C, Bollag,                G, et al.            Germline KRAS mutations cause Noonan syndrome.            Nat Genet          2006;38: 331\u20136.","DOI":"10.1038\/ng1748"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Cirstea,                IC,              Kutsche, K,                Dvorsky, R,                Gremer, L,                Carta, C,                Horn, D,              et al. A restricted spectrum of NRAS            mutations causes Noonan syndrome. Nat Genet          2010;42: 27\u20139.","DOI":"10.1038\/ng.497"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Sarkozy,              A, Carta,                C, Moretti,                S, Zampino,                G, Digilio,                MC,                Pantaleoni,              F, et al.            Germline BRAF mutations in Noonan, LEOPARD, and cardiofaciocutaneous            syndromes: molecular diversity and associated phenotypic spectrum.            Hum Mutat          2009;30: 695\u2013702.","DOI":"10.1002\/humu.20955"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Aoki,              Y, Niihori,                T, Banjo,                T, Okamoto,                N, Mizuno,                S,              Kurosawa, K,              et al. Gain-of-function mutations in RIT1            cause Noonan syndrome, a RAS\/MAPK pathway syndrome. Am J Hum            Genet          2013;93: 173\u201380.","DOI":"10.1016\/j.ajhg.2013.05.021"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Yamamoto,                GL, Aguena,                M, Gos,                M, Hung,                C, Pilch,                J,                Fahiminiya,              S, et al.            Rare variants in SOS2 and LZTR1 are associated with Noonan            syndrome. J Med Genet          2015;52: 413\u201321.","DOI":"10.1136\/jmedgenet-2015-103018"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Tartaglia,                M, Aoki,                Y, Gelb,                BD. The            molecular genetics of RASopathies: An update on novel disease genes and new            disorders. Am J Med Genet C Semin Med Genet          2022;190: 425\u201339.","DOI":"10.1002\/ajmg.c.32012"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Shoji,              Y, Ida,                S, Niihori,                T, Aoki,                Y, Okamoto,                N, Etani,                Y, et al.            Genotype-phenotype correlation analysis in Japanese patients with Noonan            syndrome. Endocr J          2019;66: 983\u201394.","DOI":"10.1507\/endocrj.EJ18-0564"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Yoshida,              R, Hasegawa,                T,              Hasegawa, Y,                Nagai, T,                Kinoshita,              E, Tanaka,                Y, et al.            Protein-tyrosine phosphatase, nonreceptor type 11 mutation analysis and            clinical assessment in 45 patients with Noonan syndrome. J Clin            Endocrinol Metab          2004;89: 3359\u201364.","DOI":"10.1210\/jc.2003-032091"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Isojima,              T, Sakazume,                S,              Hasegawa, T,                Ogata, T,                Nakanishi,              T, Nagai,                T, et al.            Growth references for Japanese individuals with Noonan            syndrome. Pediatr Res          2016;79: 543\u20138.","DOI":"10.1038\/pr.2015.254"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Tartaglia,                M, Kalidas,                K, Shaw,                A, Song,                X, Musat,                DL, van der                Burgt, I, et            al. PTPN11 mutations in Noonan syndrome: molecular            spectrum, genotype-phenotype correlation, and phenotypic heterogeneity.            Am J Hum Genet          2002;70: 1555\u201363.","DOI":"10.1086\/340847"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Zenker,              M, Buheitel,                G, Rauch,                R, Koenig,                R, Bosse,                K, Kress,                W, et al.            Genotype-phenotype correlations in Noonan syndrome.            J Pediatr          2004;144: 368\u201374.","DOI":"10.1016\/j.jpeds.2003.11.032"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Malaquias,                AC, Brasil,                AS,              Pereira, AC,                Arnhold,            IJ, Mendonca,                BB,              Bertola, DR,              et al. Growth standards of patients with            Noonan and Noonan-like syndromes with mutations in the RAS\/MAPK pathway.            Am J Med Genet A          2012;158A: 2700\u20136.","DOI":"10.1002\/ajmg.a.35519"},{"key":"22","doi-asserted-by":"publisher","unstructured":"22. Rahmouni,                K, Sigmund,                CD, Haynes,                WG, Mark,                AL.            Hypothalamic ERK mediates the anorectic and thermogenic sympathetic            effects of leptin. Diabetes          2009;58: 536\u201342.","DOI":"10.2337\/db08-0822"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Narumi,              Y, Aoki,                Y, Niihori,                T, Sakurai,                M, Cav\u00e9,                H, Verloes,                A, et al.            Clinical manifestations in patients with SOS1 mutations range from Noonan            syndrome to CFC syndrome. J Hum Genet          2008;53: 834\u201341.","DOI":"10.1007\/s10038-008-0320-0"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Aoki,              Y, Niihori,                T, Banjo,                T, Okamoto,                N, Mizuno,                S,              Kurosawa, K,              et al. Gain-of-function mutations in RIT1            cause Noonan syndrome, a RAS\/MAPK pathway syndrome. Am J Hum            Genet          2013;93: 173\u201380.","DOI":"10.1016\/j.ajhg.2013.05.021"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Komatsuzaki,                S, Aoki,                Y, Niihori,                T, Okamoto,                N,              Hennekam, RC,                Hopman, S,              et al. Mutation analysis of the SHOC2 gene            in Noonan-like syndrome and in hematologic malignancies. J Hum            Genet          2010;55: 801\u20139.","DOI":"10.1038\/jhg.2010.116"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Umeki,              I, Niihori,                T, Abe,                T, Kanno,                SI,              Okamoto, N,                Mizuno, S,              et al. Delineation of LZTR1            mutation-positive patients with Noonan syndrome and identification of LZTR1 binding to            RAF1-PPP1CB complexes. Hum Genet          2019;138: 21\u201335.","DOI":"10.1007\/s00439-018-1951-7"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Yaoita,              M, Niihori,                T, Mizuno,                S, Okamoto,                N, Hayashi,                S,              Watanabe, A,              et al. Spectrum of mutations and            genotype-phenotype analysis in Noonan syndrome patients with RIT1            mutations. Hum Genet          2016;135: 209\u201322.","DOI":"10.1007\/s00439-015-1627-5"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Kobayashi,                T, Aoki,                Y, Niihori,                T, Cav\u00e9,                H, Verloes,                A, Okamoto,                N, et al.            Molecular and clinical analysis of RAF1 in Noonan syndrome and related            disorders: dephosphorylation of serine 259 as the essential mechanism for mutant            activation. Hum Mutat          2010;31: 284\u201394.","DOI":"10.1002\/humu.21187"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Isojima,              T, Kato,                N, Ito,                Y, Kanzaki,                S, Murata,                M. Growth            standard charts for Japanese children with mean and standard deviation (SD) values based            on the year 2000 national survey. Clin Pediatr            Endocrinol          2016;25: 71\u20136.","DOI":"10.1297\/cpe.25.71"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Kato,              N, Takimoto,                H, Sudo,                N. The cubic            functions for spline smoothed L, S and M values for BMI reference data of Japanese            children. Clin Pediatr Endocrinol          2011;20: 47\u20139.","DOI":"10.1297\/cpe.20.47"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Richards,                S, Aziz,                N, Bale,                S, Bick,                D, Das,                S,                Gastier-Foster,              J, et al.            ACMG Laboratory Quality Assurance Committee.            Standards and guidelines for the interpretation of sequence variants: a            joint consensus recommendation of the American College of Medical Genetics and Genomics            and the Association for Molecular Pathology. Genet Med          2015;17: 405\u201324.","DOI":"10.1038\/gim.2015.30"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. O\u2019Reilly,                AM, Neel,                BG.            Structural determinants of SHP-2 function and specificity in Xenopus            mesoderm induction. Mol Cell Biol          1998;18: 161\u201377.","DOI":"10.1128\/MCB.18.1.161"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Papadopoulos,                G,                Papadopoulou,              A, Kosma,                K,                Papadimitriou,              A,                Papaevangelou,              V,                Kanaka-Gantenbein,              C, et al.            Molecular and clinical profile of patients referred as Noonan or            Noonan-like syndrome in Greece: a cohort of 86 patients. Eur J            Pediatr          2022;181: 3691\u2013700.","DOI":"10.1007\/s00431-022-04574-w"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Uluda\u011f                Alkaya, D,                Lissewski,              C, Ye\u015fil,                G, Zenker,                M, T\u00fcys\u00fcz,                B. Expanding            the clinical phenotype of RASopathies in 38 Turkish patients, including the rare LZTR1,            RAF1, RIT1 variants, and large deletion in NF1. Am J Med Genet            A          2021;185: 3623\u201333.","DOI":"10.1002\/ajmg.a.62410"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Bertola,                DR, Castro,                MAA,                Yamamoto,              GL, Honjo,                RS, Ceroni,                JR,                Buscarilli,              MM, et al.            Phenotype-genotype analysis of 242 individuals with RASopathies: 18-year            experience of a tertiary center in Brazil. Am J Med Genet C            Semin Med Genet          2020;184: 896\u2013911.","DOI":"10.1002\/ajmg.c.31851"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Li,                X, Yao,                R, Tan,                X, Li,                N, Ding,                Y, Li,                J, et al.            Molecular and phenotypic spectrum of Noonan syndrome in Chinese            patients. Clin Genet          2019;96: 290\u20139.","DOI":"10.1111\/cge.13588"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Draaisma,                JMT,                Drossaers,              J, van den                Engel-Hoek, L,                Leenders,            E, Geelen,                J. Young            children with Noonan syndrome: evaluation of feeding problems.            Eur J Pediatr          2020;179: 1683\u20138.","DOI":"10.1007\/s00431-020-03664-x"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. De Rocca                Serra-N\u00e9d\u00e9lec, A,                Edouard, T,                Tr\u00e9guer, K,                Tajan, M,                Araki, T,                Dance, M,              et al. Noonan syndrome-causing SHP2 mutants            inhibit insulin-like growth factor 1 release via growth hormone-induced ERK            hyperactivation, which contributes to short stature. Proc Natl            Acad Sci USA          2012;109: 4257\u201362.","DOI":"10.1073\/pnas.1119803109"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Binder,              G, Neuer,                K, Ranke,                MB,                Wittekindt,              NE. PTPN11            mutations are associated with mild growth hormone resistance in individuals with Noonan            syndrome. J Clin Endocrinol Metab          2005;90: 5377\u201381.","DOI":"10.1210\/jc.2005-0995"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Bertelloni,                S,                Baroncelli,              GI, Dati,                E, Ghione,                S,                Baldinotti,              F, Toschi,                B, et al.            IGF-I generation test in prepubertal children with Noonan syndrome due to            mutations in the PTPN11 gene. Hormones (Athens)          2013;12: 86\u201392.","DOI":"10.1007\/BF03401289"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Tajan,              M,                Pernin-Grandjean,              J, Beton,                N, Gennero,                I, Capilla,                F, Neel,                BG, et al.            Noonan syndrome-causing SHP2 mutants impair ERK-dependent chondrocyte            differentiation during endochondral bone growth. Hum Mol            Genet          2018;27: 2276\u201389.","DOI":"10.1093\/hmg\/ddy133"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Inoue,              SI, Morozumi,                N,                Yoshikiyo,              K, Maeda,                H, Aoki,                Y. C-type            natriuretic peptide improves growth retardation in a mouse model of            cardio-facio-cutaneous syndrome. Hum Mol Genet          2019;28: 74\u201383.","DOI":"10.1093\/hmg\/ddy333"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Kouz,              K, Lissewski,                C,              Spranger, S,                Mitter, D,                Riess, A,                Lopez-Gonzalez,              V, et al.            Genotype and phenotype in patients with Noonan syndrome and a RIT1            mutation. Genet Med          2016;18: 1226\u201334.","DOI":"10.1038\/gim.2016.32"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Bertola,                DR,                Yamamoto,              GL, Almeida,                TF,                Buscarilli,              M, Jorge,                AA,                Malaquias,              AC, et al.            Further evidence of the importance of RIT1 in Noonan            syndrome. Am J Med Genet A          2014;164A: 2952\u20137.","DOI":"10.1002\/ajmg.a.36722"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Chen,              PC, Yin,                J, Yu,                HW, Yuan,                T,                Fernandez,              M, Yung,                CK, et al.            Next-generation sequencing identifies rare variants associated with            Noonan syndrome. Proc Natl Acad Sci USA          2014;111: 11473\u20138.","DOI":"10.1073\/pnas.1324128111"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Cai,              W, Carlson,                SW,                Brelsfoard,              JM, Mannon,                CE,              Moncman, CL,                Saatman,            KE, et al.            Rit GTPase signaling promotes immature hippocampal neuronal            survival. J Neurosci          2012;32: 9887\u201397.","DOI":"10.1523\/JNEUROSCI.0375-12.2012"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. da                Silva, FM,                Jorge, AA,                Malaquias,              A, da Costa                Pereira, A,                Yamamoto,              GL, Kim,                CA, et al.            Nutritional aspects of Noonan syndrome and Noonan-related            disorders. Am J Med Genet A          2016;170: 1525\u201331.","DOI":"10.1002\/ajmg.a.37639"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Cessans,              C, Ehlinger,                V, Arnaud,                C, Yart,                A, Capri,                Y, Barat,                P, et al.            Growth patterns of patients with Noonan syndrome: correlation with age            and genotype. Eur J Endocrinol          2016;174: 641\u201350.","DOI":"10.1530\/EJE-15-0922"}],"container-title":["Clinical Pediatric Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/cpe\/33\/2\/33_2024-0005\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T01:05:46Z","timestamp":1711760746000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/cpe\/33\/2\/33_2024-0005\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1297\/cpe.2024-0005","relation":{},"ISSN":["0918-5739","1347-7358"],"issn-type":[{"value":"0918-5739","type":"print"},{"value":"1347-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]},"article-number":"2024-0005"}}